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Introduction:  the aim of this study was to investigate the possible relationship of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte 
ratio (PLR) and routine hematological parameters with recurrent epistaxis in children. Methods: İn this retrospective case-controlled study, 294 
patients aged between 2 and 18 years who applied to the Tokat State Hopital Ear Nose Throat Clinic due to recurrent epistaxis between January 
1st 2013 and December 31st December 2017 and 329 sex-and age-matched controls were investigated. Results: NLR was 1.45±0.75 in the study 
group and the 1.35±0.7 in the control group. There was no significant difference between the groups (p>0.05). PLR values were found 
significantly (p<0.05) higher in the study group than in the control group (103,21±29.57 vs. 97,3±30.38). Red Blood Cell Distribution Width (RDW) 
values were found significantly (p<0.05) lower in the study group than in the control group (39,56±2,87 and 38,92±2,46). Conclusion: the 
increase of PLR, an inflammatory marker, in epistaxis supports the effect of inflammatory factors in the etiology of epistaxis. However, more study 
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Epistaxis is a condition often seen in childhood and it’s rarely seen 
before 2 years of age. It was reported that the epistaxis affects 30% 
of children under 5 years and 50% of children older than 5 years of 
age [1]. Epistaxis in childhood is a condition that is self-limiting and 
rarely requires a nasal tamponade [2]. Epistaxis may originate from 
anterior and posterior according to source of bleeding. Usually, the 
nosebleeds originated from anterior septum called Little's area (also 
known as Kiesselbach's plexus) which are seen in children [3]. In the 
epistaxes of childhood, it is argued that the etiology is known in very 
few cases. Blood dyscrasia, blood vessel problems with telangiectatic 
vessels in the Little's area, and diseases causing bleeding disorder 
(von Willebrand's disease, Idiopathic Thrombocytopenic Purpura 
(ITP) are among the known reasons of epistaxis. In majority of cases 
of epistaxis, bleeding is originated from the veins in the anterior 
septum and sometimes from arteries. This last condition is known as 
"Idiopathic epistaxis" [1]. Although the tests such as prothrombin 
time (PT), activated partial thromboplastin time (aPTT) and 
international normalized ratio (INR) are the most important diagnostic 
parameters in the investigation of possible coagulation disorders, the 
levels of these parameters are normal in most of the levels of epistaxis 
[4]. 
  
Neutrophil lymphocyte ratio (NLR) and platelet to lymphocyte ratio 
(PLR) are recently used to evaluate especially systemic inflammation 
[5]. NLR is used as an easily accessible and inexpensive prognostic 
test tool in major cardiac conditions, ischemic stroke, sepsis and 
infectious diseases and its efficiency was proven [6-8]. It was shown 
that the nasal colonization of Staphylococcus aureus was higher in 
children with recurrent epistaxis than the control group [9]. It was 
claimed that the nasal colonization of Staphylococcus aureus 
stimulates the inflammation, and the risk of crusting, neo-
vascularization and increased recurrent epistaxis occured in the nasal 
septum due to this condition [10]. This situation brought the possible 
effect of inflammation on epistaxis to forefront. In previous studies, 
different blood parameters were investigated in pediatric recurrent 
epistaxis [11, 12]. In our study, we aimed to investigate especially 
inflammatory markers NLR, PLR, and some other blood parameters in 







The study was approved by the Gaziosmanpaşa University Medical 
School Clinical Research Ethics Committee. (Approval Number: 18-
KAEK-237). Two hundred and ninety four patients aged between two 
and 18 years who applied to the Tokat State Hospital. Outpatient 
Clinic due to recurrent epistaxis between January 2013 and December 
2017 were included in this retrospective, case-controlled study. The 
control group consisted of 329 age and sex matched pediatric cases 
who underwent the inguinal hernia repair and circumcision at the 
same period and who did not have any disease. Recurrent epistaxis 
was defined as the nosebleeding which occurred at least twice a 
week. The inclusion criteria for the study group and the control group 
are: (a) patients with recurrent epistaxis, (b) digital trauma (c) 
patients without any coagulation disorder and patients not receiving 
anticoagulant therapy, (d) patients without any systemic disease 
which may be the cause of bleeding, (e) patients with acute infection, 
(f) patients with chronic systemic disease. Patients with abnormal 
blood results such as anemia and leukocytosis were excluded from 
study. 
  
Blood samples of the study and control groups were obtained from 
the antecubital vein. Automated blood cell counter (Mindray BC-6800, 
Guangdong, China) was used in the measurement of complete blood 
count (CBC). Mean values found in CBC were used for statistical 
evaluation. With CBC test results, NLR value was obtained by dividing 
absolute neutrophil count by absolute lymphocyte count, and PLR 
value was obtained by dividing the absolute platelet count by absolute 
lymphocyte count. These values were used in statistical evaluation. 
  
Statistical analysis: statistical analyses were performed using SPSS 
software (SPSS 22.0, SPSS, Inc., Chicago, IL). All parameters were 
expressed as mean ± standard deviation. The Kolmogorov-Smirnow 
test was used to determine normality of distribution. Mann-Whitney 
U test was used to compare the parametric data between groups and 
student t test was used to compare the non-parametric data between 













Of the 294 patients in the pediatric epistaxis group, 145 (49.31%) 
were male and 149 (50.69%) were female. Of the 329 children in the 
control group, 160 (48.63%) were male and 169 (51.37%) were 
female. There was no statistically significant difference between 
pediatric recurrent epistaxis and control group in terms of mean age 
and gender distribution. The demographic characteristics of the study 
and control groups are shown in Table 1. When the blood parameters 
were evaluated, there was no statistical difference between the two 
groups in terms of mean NLR values, whereas it was found that the 
mean PLR value was statistically higher in the pediatric recurrent 
epistaxis group compared to the control group (p=0.11, p=0.025, 
respectively) (Figure 1, Figure 2). 
  
In addition, it was found that the mean neutrophil count (p=0.029), 
percentage of neutrophils (%) (p=0.043), platelet count (PLT) 
(p=0.001) and PLR value (p=0.025) were statistically higher in the 
recurrent epistaxis group compared to the control group (Table 1). It 
was found that Hemoglobin (Hgb) (p=0.004), Hematocrit (Hct) 
(p=0.003), Mean Corpusculer hemoglobin (MCH) (p=0.038), Mean 
Corpusculer Volume (MCV) (p=0.009) and Red cell distribution width 
(Rdw) (p=0.004) was statistically significantly lower in the recurrent 
epistaxis group than the control group. On the other hand, it was 
found that there was no statistical significant difference between the 
two groups in terms of Basophil count, percentage of Basophil (%), 
Eosinophil count, percentage of Eosinophil (%), Lymphocyte count, 
percentage of Lymphocyte (%), Mean Corpusculer Hemoglobin 
Concentration (MCHC), Monocyte count, percentage of Monocyte 
(%), Mean Platelet Volume (MPV), Platelet crit (PCT), Platelet 





One of the most important results of this study is that the PLR value 
was found to be significantly higher in the pediatric recurrent epistaxis 
group compared to the control group. However, there was no 
statistical difference between the groups in terms of NLR value that 
is another inflammatory marker. It was found that Neutrophil count, 
percentage of neutrophil, Platelet count were statistically significantly 
higher in the study group than the control group. To our knowledge, 
this present study was the first study to investigate NLR and PLR in 
pediatric recurrent epistaxis. One of the other important results of our 
study is that the Hgb, HCT, MCH, MCV and RDW levels were found to 
be significantly lower in the study group than the control group. 
  
Epistaxis is one of the most common medical conditions in childhood 
and pediatric epistaxis is one of the most common causes of 
otolaryngology admissions [1]. Digital trauma, medication, 
dehumidification, septal perforation, neoplasm, hereditary 
hemorrhagic telangiectasia, congenital bleeding disorders are among 
the causes of pediatric epistaxis [13]. In addition, nasal bacterial 
colonization (especially Staphylococcus aureus) factor was asserted 
in the etiology of pediatric recurrent epistaxis [10]. The reduction in 
bleeding frequency by antiseptic creams in children with recurrent 
epistaxis, supports nasal bacterial colonization theory [14]. Complete 
blood count is an inexpensive method used routinely. It has an 
important place in the clinic because it gives information in terms of 
the white and red blood cell count, platelet count, MPV, RDW levels 
and the parameters such as NLR and PLR [5]. 
  
The most important indicator of inflammation in CBC is the increase 
in the count of leukocytes and its subtypes. Neutrophils are the first 
defense cells of the immune system and contribute to phagocytosis 
and apoptosis through mediators secreted by them. Lymphocytes 
constitute the protective and regulating part of immunity [15]. NLR 
comes to the forefront as a biomarker used to investigate the role of 
inflammation in different diseases [5, 16]. It was found that the 
elevated NLR and PLR values were associated with poorer outcome 
and increased inflammatory process in some autoimmune diseases, 
acute pancreatitis, and in some malignant diseases [17]. In another 
study, it was found that the NLR values in infective endocarditis were 
higher in patients with high hospital mortality compared to patients 
with low hospital mortality [18]. In our study, while neutrophil count 
was found to be significantly higher in the study group than in the 
control group, no difference was found between the two groups in 
terms of NLR. Increased neutrophil count supports the possible role 
of inflammation in pediatric recurrent epistaxis. 
  
PLR was used as an indicator of systemic inflammatory response in 
recent years, although not as frequent as NLR. The expression of 
inflammatory cytokines increase with the increased platelet count 
under the inflammatory condition and in case of bleeding [5]. In 
previous studies, the increased PLR values were found in systemic 
lupus erythematosus, psoriasis vulgaris and psoriatic arthritis 
[19, 20]. There is no study performed to investigate PLR levels in 
epistaxis. On the other hand, there are three studies about the 
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change of MPV, which is an indicator of the size of the platelets and 
thus hemostatic activity in epistaxis. In the study of Kemal et al. it 
was detected that MPV values were statistically lower in the epistaxis 
group compared to the control group [21]. Similarly, in the study of 
Karabulut et al. it was found that MPV values were statistically 
significantly lower in the study group than in the control group [22]. 
However, Bezgin et al. found no statistically significant difference 
between the study group and the control group in terms of MPV value 
in their study with pediatric epistaxis patients [11]. In our study, MPV 
was found to be 9.41±0.93 in the study group and 9.45±1.02 in the 
control group. However, there was no statistically significant 
difference in terms of MPV. In the present study, the relationship 
between high PLR value and epistaxis brings to mind the 
inflammatory factors in the pathogenesis of epistaxis. The results of 
the present study and with three previous studies show that there is 
no complete consensus about the change of MPV in epistaxis. In 
future, the studies on the change of MPV in epistaxis may reveal the 
usability of MPV in prognosis. 
  
RDW is a test that is easily accessible, inexpensive and found in 
routine hemogram assay. It was often used to investigate the cause 
of anemia. In previous studies, RDW was investigated in terms of the 
risk and prognosis of the diseases such as heart failure, hepatocellular 
carcinoma [23, 24]. In the present study, we found that RDW levels 
were significantly lower in study group than the control group. This 
result was correlated with the study in adults by Kemal et al. and with 
the study in children by Bezgin et al. [11, 21]. On the other hand, in 
the study by Karabulut et al. of adult patients with epistaxis, RDW 
values were found to be significantly higher in study group than the 
control group. Bezgin et al. asserted that decreased RDW level in 
recurrent epistaxis was due to its anti-thrombotic activity and the 
recurrent epistaxis may occur because of this reason [11]. 
Salvagno et al. asserted that the increase of RDW levels due to 
increased bleeding stress were an expected result [25]. In contrast, 
the decreased RDW values in epistaxis found in our study may provide 





 In our study, there was no correlation between NLR and recurrent 
epistaxis, whereas PLR values were found to be higher in epistaxis 
group. Low RDW values were found in the recurrent epistaxis group. 
According to the results of present study, the increase of PLR, an 
inflammatory marker, in epistaxis supports the effect of inflammatory 
factors in the etiology of epistaxis. However, more study in future is 
needed to support this. 
 
 
What is known about this topic 
 Inflammation can cause epistaxis in children; 
 Epistaxis is usually seen in pediatric patients; 
 Epistaxis is usually idiopathic. 
 
What this study adds 
 
 Neutrophil lymphocyte ratio (NLR) and platelet to 
lymphocyte ratio (PLR) was studied first in this study 
according to previous literature; 
 Results of this study is showing that inflammation can 
play a role in pediatric epistaxis; 
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Table 1: the demographic and clinical features of the Study populations (Patients and Controls) 
Variables Control Group (n=329) Study group (n=296) p 
 Mean±SD Mean±SD  
Age 9±4.78 9,16±4.23 0.338 
Sex    
Male 160 145  
Female 169 149  
NLR 1.35±0.7 1.45±0.75 0.11 
PLR 97.3±30.38 103.21±29.57 0.025 
Hemoglobin g/dL 13.19±1.45 12.92±1.27 0.004 
HCT % 39.62±4.15 38.74±3.62 0.003 
MCV fL 81.55±6.02 80.72±4.96 0.009 
MCH pg 27.17±2.33 26.92±1.91 0.038 
MCHC g/dL 35.88±26.88 35.4±24.79 0.569 
RDW % 39.56±2.87 38.92±2.46 0.004 
PLT 103 /u 278.43±57.99 293.15±56.12 0,001 
MPV fL 9.45±1.02 9.41±0.93 0.566 
PCT % 0.65±0.87 0.61±0.86 0.444 
PDW % 15.36±1.37 15.08±1.81 0.104 
WBC 103 /u 7.59±1.57 7.81±1.87 0.115 
Neutrophil % 48.63±10.92 50.41±10.99 0.043 
Lymphocytes % 40.74±10.58 39.52±10.24 0.143 
Monocytes % 6.53±1.66 6.49±1.82 0.499 
Eosinophils % 3.6±2.95 3.23±2.68 0.099 
Basophil, % 0.39±0.22 0.37±0.2 0.256 
Neutrophil 103 /u 3.73±1.29 4.03±1.57 0.029 
Lymphocytes, 3.08±0.98 3.02±0.85 0.647 
Monocytes 103 /u 0.49±0.15 0.5±0.16 0.926 
Eosinophils 103 /u 0.28±0.24 0.26±0.23 0.148 
Basophil 103 /u 0.03±0.02 0.03±0.02 0.229 
SD, Standart Deviation; HCT, hematocrit; MCH, mean corpuscular hemoglobin; MCHC, mean 
corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MPV, mean platelet 
volume; NLR, neutrophil-to-lymphocyte ratio; PCT, platelet crit; PDW, platelet distribution width; 
PLR, platelet-to-lymphocyte ratio; PLT, platelet; RBC, red blood cell; RDW, red cell distribution 
width; WBC, white blood cell. p< 0.05 value was regarded as significant. The significant 
differences between the groups are shown in bold. 
* Student t test 
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Figure 2: the mean Platelet to lymphocyte ratio (PLR) values of the epistaxis group and the control 
group 
 
 
 
 
 
 
